COVID-19 相关隐球菌感染（CACI）：文献回顾与临床要点。

COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls.

机构信息

Division of Infectious Diseases, Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

Department of Pharmacy, Ochsner LSU Health Shreveport, Shreveport, LA, USA.

出版信息

Infection. 2022 Aug;50(4):1007-1012. doi: 10.1007/s15010-022-01805-y. Epub 2022 Mar 24.

DOI:10.1007/s15010-022-01805-y

PMID:35322336

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8942802/

Abstract

BACKGROUND

Cryptococcal infection has been increasingly reported in patients with COVID-19 infection, but the epidemiological factors, presentation, diagnostic certainty, and outcome have not been well-described.

METHODS

We reviewed the published cases of COVID-19-associated Cryptococcus infections (CACI) to shed the light on the burden of this infection.

RESULTS

We identified 13 patients with confirmed cryptococcal infection. Cryptococcus infection was primarily seen in patients with severe COVID-19 disease who received corticosteroids therapy and admitted to the intensive care unit. Pulmonary CACI was the most common reported infection followed by cryptococcal meningitis.

CONCLUSION

In light of the high mortality rate, clinicians should maintain a high clinical suspicion of CACI in critically ill patients.

摘要

背景

COVID-19 感染患者中越来越多地报告了隐球菌感染，但该病的流行病学因素、表现、诊断确定性和结局尚未得到很好描述。

方法

我们回顾了已发表的 COVID-19 相关隐球菌感染（CACI）病例，以了解该病的负担。

结果

我们共确定了 13 例确诊的隐球菌感染患者。隐球菌感染主要见于接受皮质类固醇治疗并入住重症监护病房的重症 COVID-19 患者。肺部 CACI 是最常见的报道感染，其次是隐球菌性脑膜炎。

结论

鉴于高死亡率，临床医生应在重症患者中对 CACI 保持高度临床怀疑。

相似文献

COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls.

Infection. 2022 Aug;50(4):1007-1012. doi: 10.1007/s15010-022-01805-y. Epub 2022 Mar 24.

Preventing deaths from cryptococcal meningitis: from bench to bedside.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):715-7. doi: 10.1586/eri.11.86.

Cryptococcal meningitis post-covid-19 infection: Immunomodulation, a double-edged sword.

J Infect Dev Ctries. 2023 May 31;17(5):623-630. doi: 10.3855/jidc.17170.

[Cryptococcosis].

Nihon Rinsho. 2008 Dec;66(12):2350-5.

Cryptococcus endocarditis: A case report and review of the literature.

J Infect Chemother. 2019 Nov;25(11):901-905. doi: 10.1016/j.jiac.2019.05.003. Epub 2019 Jun 8.

[Cryptococcosis--a common fungal infection in immunosuppressed patient].

Pneumologia. 2014 Jul-Sep;63(3):156, 159-63.

Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.

BMC Infect Dis. 2019 Mar 4;19(1):220. doi: 10.1186/s12879-019-3831-8.

Glucocorticoids, COVID-19 and Cryptococcosis.

Antiinflamm Antiallergy Agents Med Chem. 2023;22(2):67-70. doi: 10.2174/1871523022666230912142540.

Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient.

BMC Neurol. 2022 Jul 6;22(1):247. doi: 10.1186/s12883-022-02773-4.

Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation.

Mycoses. 2020 Oct;63(10):1033-1046. doi: 10.1111/myc.13153. Epub 2020 Aug 23.

引用本文的文献

Global, Regional, and National Burden of Pulmonary Fungal Infections 1990-2021.

Am J Respir Crit Care Med. 2025 Jun;211(6):1007-1017. doi: 10.1164/rccm.202410-2076OC.

Screening of Candida spp. in wastewater in Brazil during COVID-19 pandemic: workflow for monitoring fungal pathogens.

BMC Biotechnol. 2024 Jun 22;24(1):43. doi: 10.1186/s12896-024-00868-z.

Pleiotropic roles of LAMMER kinase, Lkh1 in stress responses and virulence of .

Front Cell Infect Microbiol. 2024 May 7;14:1369301. doi: 10.3389/fcimb.2024.1369301. eCollection 2024.

Case report: Experience and insights on the treatment of two cases of cryptococcal meningitis during the later stages of the COVID-19 pandemic.

Front Immunol. 2024 Apr 22;15:1361277. doi: 10.3389/fimmu.2024.1361277. eCollection 2024.

Endobronchial cryptococcosis without pulmonary parenchymal involvement caused by in an immunocompetent host.

Respirol Case Rep. 2024 Apr 3;12(4):e01343. doi: 10.1002/rcr2.1343. eCollection 2024 Apr.

Developing Crowdsourced Clinical Registry Studies.

Am J Nurs. 2024 Apr 1;124(4):36-41. doi: 10.1097/01.NAJ.0001010572.96486.87. Epub 2024 Mar 21.

Funding for research on cryptococcal disease: an analysis based on the G-finder report.

IMA Fungus. 2024 Mar 2;15(1):4. doi: 10.1186/s43008-023-00133-6.

Antifungal Resistance in Cryptococcal Infections.

Pathogens. 2024 Jan 29;13(2):128. doi: 10.3390/pathogens13020128.

COVID-19 associated with cryptococcosis: a scoping review.

Ther Adv Infect Dis. 2024 Feb 14;11:20499361241232851. doi: 10.1177/20499361241232851. eCollection 2024 Jan-Dec.

Meningeal cryptococcosis and SARS-CoV-2 infection in people living with HIV/AIDS.

Biomedica. 2023 Aug 31;43(Sp. 1):206-216. doi: 10.7705/biomedica.6872.

本文引用的文献

Pulmonary aspergillosis and cryptococcosis as a complication of COVID-19.

Med Mycol Case Rep. 2022 Mar;35:22-25. doi: 10.1016/j.mmcr.2022.01.003. Epub 2022 Jan 6.

Fatal case of disseminated cryptococcal infection and meningoencephalitis in the setting of prolonged glucocorticoid use in a Covid-19 positive patient.

IDCases. 2022;27:e01380. doi: 10.1016/j.idcr.2022.e01380. Epub 2022 Jan 6.

Cryptococcal Meningoencephalitis During Convalescence From Severe COVID-19 Pneumonia.

Neurohospitalist. 2022 Jan;12(1):96-99. doi: 10.1177/19418744211009766. Epub 2021 May 3.

The Emergence of Cryptococcemia in COVID-19 Infection: A Case Report.

Cureus. 2021 Nov 20;13(11):e19761. doi: 10.7759/cureus.19761. eCollection 2021 Nov.

Disseminated infection associated to COVID-19.

Med Mycol Case Rep. 2021 Dec;34:35-37. doi: 10.1016/j.mmcr.2021.10.001. Epub 2021 Oct 22.

Opportunistic Fungal Infection Associated With COVID-19.

Open Forum Infect Dis. 2021 Jan 18;8(7):ofab016. doi: 10.1093/ofid/ofab016. eCollection 2021 Jul.

blood stream infection in severe COVID-19 pneumonia.

IDCases. 2021;26:e01274. doi: 10.1016/j.idcr.2021.e01274. Epub 2021 Aug 31.

[Rare superinfection in a COVID-19 patient-A chronology].

Anaesthesist. 2022 Jan;71(1):38-49. doi: 10.1007/s00101-021-01018-2. Epub 2021 Aug 24.

Coronavirus Disease 2019-Associated Mucormycosis: Risk Factors and Mechanisms of Disease.

Clin Infect Dis. 2022 Apr 9;74(7):1279-1283. doi: 10.1093/cid/ciab726.

Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants.

J Fungi (Basel). 2021 Jul 9;7(7):545. doi: 10.3390/jof7070545.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

COVID-19 相关隐球菌感染（CACI）：文献回顾与临床要点。

COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls.

机构信息

Division of Infectious Diseases, Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

Department of Pharmacy, Ochsner LSU Health Shreveport, Shreveport, LA, USA.

出版信息

Infection. 2022 Aug;50(4):1007-1012. doi: 10.1007/s15010-022-01805-y. Epub 2022 Mar 24.

DOI:10.1007/s15010-022-01805-y

PMID:35322336

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8942802/

Abstract

BACKGROUND

METHODS

We reviewed the published cases of COVID-19-associated Cryptococcus infections (CACI) to shed the light on the burden of this infection.

RESULTS

CONCLUSION

In light of the high mortality rate, clinicians should maintain a high clinical suspicion of CACI in critically ill patients.

摘要

背景

COVID-19 感染患者中越来越多地报告了隐球菌感染，但该病的流行病学因素、表现、诊断确定性和结局尚未得到很好描述。

方法

我们回顾了已发表的 COVID-19 相关隐球菌感染（CACI）病例，以了解该病的负担。

结果

结论

鉴于高死亡率，临床医生应在重症患者中对 CACI 保持高度临床怀疑。

COVID-19 相关隐球菌感染（CACI）：文献回顾与临床要点。

COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls.

机构信息

出版信息

BACKGROUND

METHODS

RESULTS

CONCLUSION

背景

方法

结果

结论

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

COVID-19 相关隐球菌感染（CACI）：文献回顾与临床要点。

COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls.

机构信息

出版信息

BACKGROUND

METHODS

RESULTS

CONCLUSION

背景

方法

结果

结论